120 related articles for article (PubMed ID: 18611618)
1. Activities of liposome-encapsulated azithromycin and rifabutin compared with that of clarithromycin against Mycobacterium avium-intracellulare complex in human macrophages.
Onyeji CO; Nightingale CH; Nicolau DP; Quintiliani R
Int J Antimicrob Agents; 1994; 4(4):281-9. PubMed ID: 18611618
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.
Onyeji CO; Nightingale CH; Nicolau DP; Quintiliani R
Antimicrob Agents Chemother; 1994 Mar; 38(3):523-7. PubMed ID: 8203849
[TBL] [Abstract][Full Text] [Related]
3. Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare.
Onyeji CO; Nightingale CH; Tessier PR; Nicolau DP; Bow LM
J Infect Dis; 1995 Sep; 172(3):810-6. PubMed ID: 7658075
[TBL] [Abstract][Full Text] [Related]
4. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
[TBL] [Abstract][Full Text] [Related]
5. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.
Majumdar S; Flasher D; Friend DS; Nassos P; Yajko D; Hadley WK; Düzgüneş N
Antimicrob Agents Chemother; 1992 Dec; 36(12):2808-15. PubMed ID: 1482150
[TBL] [Abstract][Full Text] [Related]
6. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
[TBL] [Abstract][Full Text] [Related]
7. Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.
Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Pocidalo JJ; Vilde JL
Antimicrob Agents Chemother; 1990 Aug; 34(8):1508-11. PubMed ID: 2171421
[TBL] [Abstract][Full Text] [Related]
8. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental
Grewal TK; Majeed S; Sharma S
Indian J Med Res; 2018 Jun; 147(6):594-602. PubMed ID: 30168492
[TBL] [Abstract][Full Text] [Related]
10. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
Uthman MM; Uthman OA; Yahaya I
Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
[TBL] [Abstract][Full Text] [Related]
11. Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages.
Salem II; Düzgünes N
Int J Pharm; 2003 Jan; 250(2):403-14. PubMed ID: 12527166
[TBL] [Abstract][Full Text] [Related]
12. MAC management.
PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
[TBL] [Abstract][Full Text] [Related]
13. Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS.
Benson CA
Clin Infect Dis; 1994 Apr; 18 Suppl 3():S237-42. PubMed ID: 8204776
[TBL] [Abstract][Full Text] [Related]
14. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
[TBL] [Abstract][Full Text] [Related]
16. Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium.
Mor N; Vanderkolk J; Mezo N; Heifets L
Antimicrob Agents Chemother; 1994 Dec; 38(12):2738-42. PubMed ID: 7695255
[TBL] [Abstract][Full Text] [Related]
17. Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease.
Kuper JI; D'Aprile M
Clin Pharmacokinet; 2000 Sep; 39(3):203-14. PubMed ID: 11020135
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of liposome-encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice.
Tomioka H; Saito H; Sato K; Yoneyama T
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):575-9. PubMed ID: 1892297
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial synergism of clarithromycin and rifabutin.
Ghebremichael S; Svenson SB; Källenius G; Hoffner SE
Scand J Infect Dis; 1996; 28(4):387-90. PubMed ID: 8893404
[TBL] [Abstract][Full Text] [Related]
20. Liposome-encapsulated antibiotics.
Salem II; Flasher DL; Düzgüneş N
Methods Enzymol; 2005; 391():261-91. PubMed ID: 15721386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
